oncology

"Demis Hassabis described how Google DeepMind has accelerated its pace over the past two to three years by merging Google Brain’s compute resources with DeepMind’s research culture and returning to what he called a “startup or entrepreneurial” way of working."

The Next Web

* Cited for critical analysis under Article 32.

Permalink The Next Web

Mapping ADC Research with AI: A New Frontier in Oncology

Zenn NLP•Mar 28, 2026 02:05•research▸

research #embeddings 📝 Blog|Analyzed: Mar 28, 2026 11:45•

Published: Mar 28, 2026 02:05

•

1 min read

•Zenn NLP

Analysis

This research utilizes cutting-edge AI techniques to visualize the complex landscape of Antibody-Drug Conjugate (ADC) research, a rapidly growing area in oncology. By leveraging PubMed, Vertex AI Embeddings, and clustering algorithms, this approach offers a novel way to navigate and understand the vast amount of literature in this field, potentially accelerating discoveries. The use of Gemini for interpreting clusters is a particularly interesting application of Generative AI.

Key Takeaways & Reference▶

•The project uses PubMed, the go-to resource for biomedical literature.
•Vertex AI Embeddings converts text into vectors for analysis.
•Gemini is employed to translate research clusters into plain language.

Reference / Citation

"PubMed API（Biopython）で論文タイトル＋アブストラクトを一括取得 Vertex AI Embeddings でテキストをベクトル化 UMAP で2次元に次元削減 HDBSCAN でクラスタリング Gemini でクラスターを自然言語で解釈"

Zenn NLP

* Cited for critical analysis under Article 32.

Permalink Zenn NLP

Boosting Canine Cancer Research with AI: Innovative Relation Extraction Strategy

r/LanguageTechnology•Mar 11, 2026 04:37•research▸

research #nlp 👥 Community|Analyzed: Mar 11, 2026 04:49•

Published: Mar 11, 2026 04:37

•

1 min read

•r/LanguageTechnology

Analysis

This research explores an exciting application of AI in veterinary oncology! The use of specialized NER models, SciBERT and BioBERT, to analyze scientific papers offers a fresh approach. The focus on low-resource infrastructure is particularly interesting, suggesting potential for wider accessibility.

Key Takeaways & Reference▶

•Utilizing Fine-tuning NER models (SciBERT & BioBERT) for scientific paper analysis.
•Focuses on extracting relations between Machine Learning and Veterinary Oncology entities.
•Addresses the challenge of Relation Extraction within low-resource environments.

Reference / Citation

Permalink r/LanguageTechnology

"I have two fine-tuned NER models (SciBERT for ML entities and BioBERT for Vet Oncology). Now I need to extract relations between them (e.g., MODEL 'X' used for DIAGNOSING 'Y')."

r/LanguageTechnology

* Cited for critical analysis under Article 32.

AI-Powered Drug Repurposing: A Promising New Frontier

Qiita AI•Feb 9, 2026 03:59•research▸

research #llm 📝 Blog|Analyzed: Feb 9, 2026 04:00•

Published: Feb 9, 2026 03:59

•

1 min read

•Qiita AI

Analysis

This article introduces a system that leverages AI to assist in drug repositioning, focusing on identifying promising candidates rather than guaranteeing efficacy. The approach is designed to provide valuable insights for researchers exploring new therapeutic options, particularly in areas like oncology. The emphasis on candidate identification is a refreshing take on the potential of AI in pharmaceutical research.

Key Takeaways & Reference▶

•The article focuses on using AI to identify potential drug candidates for repurposing.
•It emphasizes the importance of distinguishing between candidate identification and guaranteed efficacy.
•The system is designed to aid researchers in exploring new therapeutic options.

Reference / Citation

"This system is not about finding 'effective drugs'. It is about presenting 'candidates worth investigating'."

Qiita AI

* Cited for critical analysis under Article 32.

Permalink Qiita AI

AstraZeneca Leans Into In-House AI for Oncology Research Acceleration

AI News•Jan 14, 2026 10:00•business▸

business #ai 📝 Blog|Analyzed: Jan 14, 2026 10:15•

Published: Jan 14, 2026 10:00

•

1 min read

•AI News

Analysis

The article highlights the strategic shift of pharmaceutical giants towards in-house AI development to address the burgeoning data volume in drug discovery. This internal focus suggests a desire for greater control over intellectual property and a more tailored approach to addressing specific research challenges, potentially leading to faster and more efficient development cycles.

Key Takeaways & Reference▶

•AstraZeneca is investing in in-house AI capabilities.
•The focus is on integrating AI into research and clinical workflows.
•The goal is to accelerate oncology drug development.

Reference / Citation

"The challenge is no longer whether AI can help, but how tightly it needs to be built into research and clinical work to improve decisions around trials and treatment."

AI News

* Cited for critical analysis under Article 32.

Permalink AI News

HARMON-E: AI Extracts Structured Data from Oncology Notes

ArXiv•Dec 22, 2025 20:38•Research▸

Research #Agent 🔬 Research|Analyzed: Jan 10, 2026 08:25•

Published: Dec 22, 2025 20:38

•

1 min read

•ArXiv

Analysis

This research paper introduces HARMON-E, a novel approach using hierarchical agentic reasoning for extracting structured data from unstructured oncology notes. The focus on multimodal data processing indicates a potential for robust and comprehensive data extraction in a complex domain.

Key Takeaways & Reference▶

•HARMON-E aims to structure data from multimodal oncology notes.
•The method utilizes hierarchical agentic reasoning.
•The research is published on ArXiv indicating ongoing development.

Reference / Citation

"HARMON-E leverages hierarchical agentic reasoning."

* Cited for critical analysis under Article 32.

AI-Powered Patient Selection: Identifying Low-Risk Oncology Patients for Improved Survival

ArXiv•Dec 19, 2025 22:52•Research▸

Research #Oncology 🔬 Research|Analyzed: Jan 10, 2026 09:20•

Published: Dec 19, 2025 22:52

•

1 min read

•ArXiv

Analysis

This research, published on ArXiv, explores the application of AI in oncology to improve patient outcomes. The focus on distribution-free methods suggests a robust approach that could be less susceptible to biases inherent in data assumptions.

Key Takeaways & Reference▶

•Applies AI to identify oncology patients with a higher likelihood of long-term survival.
•Utilizes distribution-free methods, potentially enhancing the reliability of patient selection.
•This research aims to improve patient outcomes through AI-driven risk assessment.

Reference / Citation

"The research focuses on the distribution-free selection of low-risk oncology patients."

* Cited for critical analysis under Article 32.

AI-Powered Consensus for Oncology: A Collaborative Framework

ArXiv•Dec 16, 2025 11:35•Research▸

Research #Multi-agent 🔬 Research|Analyzed: Jan 10, 2026 10:47•

Published: Dec 16, 2025 11:35

•

1 min read

•ArXiv

Analysis

This research explores a multi-agent system for collaborative medical decision-making in oncology, potentially improving diagnostic accuracy and treatment planning. The ArXiv publication suggests an early-stage exploration with implications for improving MDT consultations and patient care.

Key Takeaways & Reference▶

•Focuses on a multi-agent system for medical decision making.
•Specifically targets oncology MDT consultations.
•Published on ArXiv, indicating potential early-stage research.

Reference / Citation

"The study focuses on a Multi-Agent Medical Decision Consensus Matrix System for oncology MDT consultations."

* Cited for critical analysis under Article 32.

AI Agents Enhance Decision-Making in Gastrointestinal Oncology

ArXiv•Dec 9, 2025 14:56•Research▸

Research #AI Agent 🔬 Research|Analyzed: Jan 10, 2026 12:33•

Published: Dec 9, 2025 14:56

•

1 min read

•ArXiv

Analysis

This research explores the application of multi-agent systems to improve decision-making processes within the complex domain of gastrointestinal oncology. The use of AI agents holds promise for assisting clinicians in navigating the complexities of diagnosis and treatment planning.

Key Takeaways & Reference▶

•Multi-agent AI systems are utilized to improve decision making.
•The focus is on multidisciplinary decision making in the context of gastrointestinal oncology.
•This research highlights the potential of AI to aid clinical practices.

Reference / Citation

"Multi-agent intelligence is being applied to gastrointestinal oncology."

* Cited for critical analysis under Article 32.

Spatial Analysis Techniques for AI-Driven Histopathology

ArXiv•Dec 5, 2025 19:44•Research▸

Research #Histopathology 🔬 Research|Analyzed: Jan 10, 2026 12:59•

Published: Dec 5, 2025 19:44

•

1 min read

•ArXiv

Analysis

This ArXiv article likely presents novel methods for analyzing histopathology images, offering potential improvements in disease diagnosis and treatment. The paper's focus on spatial analysis suggests a deeper understanding of cellular relationships within tissue samples.

Key Takeaways & Reference▶

•Explores methods for analyzing the spatial relationships of cells in histopathology images.
•Utilizes AI segmentation for improved image analysis accuracy.
•Potentially aids in more precise diagnosis and treatment planning in oncology.

Reference / Citation

"The article's focus is on spatial analysis within AI-segmented histopathology images."

* Cited for critical analysis under Article 32.

AI Predicts IDH1 Mutations in Low-Grade Glioma Using Multimodal Data

ArXiv•Dec 5, 2025 15:43•Research▸

Research #Oncology Agent 🔬 Research|Analyzed: Jan 10, 2026 13:01•

Published: Dec 5, 2025 15:43

•

1 min read

•ArXiv

Analysis

This ArXiv article suggests a promising application of AI in oncology, specifically for predicting IDH1 mutations in low-grade gliomas. The use of multimodal data suggests a potentially more accurate and comprehensive diagnostic tool, leading to more informed treatment decisions.

Key Takeaways & Reference▶

•AI is being applied to predict genetic mutations in cancer.
•The research utilizes multimodal data for prediction.
•The target is low-grade glioma, a type of brain tumor.

Reference / Citation

"The research focuses on the prediction of IDH1 mutations in low-grade glioma."

* Cited for critical analysis under Article 32.

LLM Reasoning Biases Threaten Oncology Note Interpretation

ArXiv•Nov 16, 2025 21:13•Research▸

Research #LLM Bias 🔬 Research|Analyzed: Jan 10, 2026 14:43•

Published: Nov 16, 2025 21:13

•

1 min read

•ArXiv

Analysis

This research highlights a critical vulnerability in the use of Large Language Models (LLMs) within healthcare. The findings underscore the importance of mitigating cognitive biases in LLMs to ensure accurate and reliable interpretation of clinical data.

Key Takeaways & Reference▶

•LLMs can exhibit cognitive biases that affect their ability to accurately interpret medical information.
•This research focuses on the interpretation of clinical oncology notes.
•Mitigating bias is crucial for ensuring the reliability of LLMs in healthcare.

Reference / Citation

"Cognitive bias in LLM reasoning compromises interpretation of clinical oncology notes."

* Cited for critical analysis under Article 32.